Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Editas Medicine, Inc. (EDIT) had Free Cash Flow per Share of $-1.16 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$3.58M |
|
$-53.23M |
|
-- |
|
$3.58M |
|
$55.12M |
|
$-51.54M |
|
$-1.69M |
|
$-53.23M |
|
$-53.23M |
|
$-53.23M |
|
$-53.23M |
|
$-53.23M |
|
$-53.23M |
|
$-51.54M |
|
$-49.97M |
|
84.41M |
|
84.41M |
|
$-0.63 |
|
$-0.63 |
|
| Balance Sheet Financials | |
$182.80M |
|
$4.58M |
|
$27.79M |
|
$210.58M |
|
$65.94M |
|
-- |
|
$125.45M |
|
$191.39M |
|
$19.19M |
|
$19.19M |
|
$19.19M |
|
87.39M |
|
| Cash Flow Statement Financials | |
$-98.01M |
|
$99.04M |
|
$5.97M |
|
$135.42M |
|
$142.42M |
|
$7.00M |
|
$5.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1440.58% |
|
-1440.58% |
|
-- |
|
-1487.84% |
|
-1487.84% |
|
$-97.97M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
6.08 |
|
14.79 |
|
-277.42% |
|
-277.42% |
|
-25.28% |
|
-277.42% |
|
$0.22 |
|
|
Free Cash Flow per Share |
$-1.16 |
$-1.16 |
|